

News
Agnelli Family To Inject Funds Into Juventus Amid Financial Concerns
Juventus may require additional funds to stabilize its finances following the departure of manager Thiago Motta.
The Italian club announced that its main shareholder has committed to providing 15 million euros ($16 million) in anticipation of a possible share issuance.
Juventus, which has been controlled by the Agnelli family for a century, has been forced to raise around 900 million euros from its shareholders over the past six years.
Exor, owned by the Agnelli family, has agreed to provide a cash contribution of 15 million euros in anticipation of a potential future share issue, the club announced late on Friday.
This month, Juventus replaced Motta with former player Igor Tudor after two consecutive heavy defeats in a disappointing season, with the club standing fifth in Serie A.
The club stated that recent on-field performance and Motta’s departure had led them to reevaluate the results for this quarter and the next, along with the outlook for the 2025/26 financial year.
Juventus’ financial year runs from July 1st to June 30th.
The club stated that its overall targets under the plan through 2027 remain intact.
However, the review has highlighted a potential need for a cash injection, which could range from 15 million euros up to 10% of its market value.
Juventus was worth 1.14 billion euros at Friday’s closing price.
Exor could cover the cash call in full but would invest at least enough to keep its stake unchanged, Juventus said.
A final decision on the capital hike will be taken after the current season and the summer transfer campaign for players.
Juventus swung to a profit in the first half of this fiscal year, thanks to its return to Europe’s lucrative Champions League competition, but it does not expect a net profit for the full year.
The club faced a 10-point deduction in the 2022/23 season and was banned from European competitions in 2023/24 due to accounting issues.
It has denied any wrongdoing, stating that its accounting practices align with industry standards.